|
|
|
Corona update from the ECNP President
ECNP President Gitte Knudsen talks about the coronavirus and the upcoming ECNP Congress.
|
|
|
|
ECNP corona diary
The first of our frontline corona reports: Damiaan Denys, professor of Psychiatry at the University of Amsterdam, discusses the challenges of patient care in the corona crisis and some of the key clinical lessons-learned so far.
|
|
|
|
Early registration deadline extended to 1 June 2020
We know that for many in the ECNP community making plans is difficult in the current environment. To make it easier for you, and to give you as much flexibility as possible, we are extending the early registration deadline to 1 June 2020.
And don’t forget: if you register for the congress, you can cancel right up to 1 August, with a refund. Read more.
|
|
|
|
33rd ECNP Congress - Top Paper Sessions
For finding out about the latest developments in clinical research, check out our Top Paper Sessions, a great way to get up-to-speed with the latest developments in this field.
During six 30-minute sessions, top researchers will discuss the must-read papers for clinicians published in the past 12 months
Discover our programme and find out more about bios and outlines by clicking on the button below.
|
|
|
|
Six new ECNP Fellows appointed
ECNP is pleased to announce six new Fellows, appointed for their scientific eminence and contributions to the College:
- Roger Adan, The Netherlands
- Josephina Castro-Fornieles, Spain
- Hagit Cohen, Israel
- Suzanne Dickson, Sweden
- Stefan Leucht, Germany
- Ana Pinto, Spain
For information on how to apply to become an ECNP Fellow, read here.
|
|
|
|
Early Career Researcher with an interest in autism?
Attend our first remote Early Career Researcher Autism Network (ECRAN) workshop on July 6-8. Early Career Researchers with a research interest in autism can join via http://bit.ly/joinecran and register for the workshop via http://bit.ly/ecranworkshop2020.
The ECRAN is part of AIMS-2-TRIALS (Autism Innovative Medicine Studies - 2 - Trials), a five-year, € 113- million European research project that will explore the biology of autism to develop new treatments tailored to individual needs. Read more.
AIMS-2-TRIALS is one of the EU research projects supported by ECNP.
|
|
|
|
|
|